FDO Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,701
Closed -$1.22M 282
2017
Q3
$1.22M Sell
8,701
-6,557
-43% -$920K 0.49% 85
2017
Q2
$1.86M Buy
15,258
+11,158
+272% +$1.36M 0.4% 112
2017
Q1
$497K Buy
+4,100
New +$497K 0.12% 172